Low platelet counts after liver transplantation predict early posttransplant survival: The 60‐5 criterion

Platelets play a critical role in liver injury and regeneration. Thrombocytopenia is associated with increases in postoperative complications after partial hepatectomy, but it is unknown whether platelet counts could also predict outcomes after transplantation, a procedure that is often performed in thrombocytopenic patients. Therefore, the aim of this study was to evaluate whether platelet counts could be indicators of short‐ and long‐term outcomes after liver transplantation (LT). Two hundred fifty‐seven consecutive LT recipients (January 2003‐December 2011) from our prospective database were analyzed. Preoperative and daily postoperative platelet counts were recorded until postoperative day 7 (POD7). Univariate and multivariate analyses were performed to assess whether low perioperative platelet counts were a risk factor for postoperative complications and graft and patient survival. The median pretransplant platelet count was 88 × 109/L [interquartile range (IQR) = 58‐127 × 109/L]. The lowest platelet counts occurred on POD3: the median was 56 × 109/L (IQR = 41‐86 × 109/L). Patients with low platelet counts on POD5 had higher rates of severe (grade IIIb/IV) complications [39% versus 29%, odds ratio (OR) = 1.09 (95% CI = 1.1‐3.3), P = 0.02] and 90‐day mortality [16% versus 8%, OR = 2.25 (95% CI = 1.0‐5.0), P = 0.05]. In the multivariate analysis, POD5 platelet counts < 60 × 109/L were identified as an independent risk factor for grade IIIb/IV complications [OR = 1.96 (95% CI = 1.07‐3.56), P = 0.03)], graft survival [hazard ratio (HR) = 2.0 (95% CI = 1.1‐3.6), P = 0.03)], and patient survival [HR = 2.2 (95% CI = 1.1‐4.6), P = 0.03)]. The predictive value of platelet counts for graft and patient survival was lost in patients who survived 90 days. In conclusion, after LT, platelet counts < 60 × 109/L on POD5 (the 60‐5 criterion) are an independent factor associated with severe complications and early graft and patient survival. These findings may help us to develop protective strategies or specific interventions for high‐risk patients. Liver Transpl 20:147‐155, 2014. © 2013 AASLD.

[1]  R. Parker.  Etiology and significance of thrombocytopenia in critically ill patients. , 2012, Critical care clinics.

[2]  P. Coriat,et al.  Thrombocytopenia, splenomegaly, and portal blood flow in patients who have undergone liver transplantation for cirrhosis , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  D. Raptis,et al.  The model for end‐stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  N. Ohkohchi,et al.  Platelet Administration Via the Portal Vein Promotes Liver Regeneration in Rats After 70% Hepatectomy , 2011, Annals of surgery.

[5]  S. Maithel,et al.  Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. , 2011, Journal of the American College of Surgeons.

[6]  W. Jochum,et al.  Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway , 2011, Proceedings of the National Academy of Sciences.

[7]  M. Lesurtel,et al.  Activation of serotonin receptor‐2B rescues small‐for‐size liver graft failure in mice , 2011, Hepatology.

[8]  K. Lee,et al.  Platelet Transfusion can be Related to Liver Regeneration After Living Donor Liver Transplantation , 2010, World Journal of Surgery.

[9]  M. Kinkhabwala,et al.  Hypothermic Machine Preservation in Human Liver Transplantation: The First Clinical Series , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  M. Nijsten,et al.  Immediate Postoperative Low Platelet Count is Associated With Delayed Liver Function Recovery After Partial Liver Resection , 2010, Annals of surgery.

[11]  J. Emond,et al.  Survival Outcomes Following Liver Transplantation (SOFT) Score: A Novel Method to Predict Patient Survival Following Liver Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  N. Ohkohchi,et al.  Role of platelets on liver regeneration after 90% hepatectomy in mice. , 2008, Journal of hepatology.

[13]  R. Porte,et al.  Platelets in liver transplantation: Friend or foe? , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  F. Nevens,et al.  Review article: blood platelet number and function in chronic liver disease and cirrhosis , 2008, Alimentary pharmacology & therapeutics.

[15]  N. Ohkohchi,et al.  Platelets Promote Liver Regeneration under Conditions of Kupffer Cell Depletion after Hepatectomy in Mice , 2008, World Journal of Surgery.

[16]  R. Porte,et al.  The Impact of Intraoperative Transfusion of Platelets and Red Blood Cells on Survival After Liver Transplantation , 2008, Anesthesia and analgesia.

[17]  E. Elm,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[18]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[19]  Matthias Egger,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.

[20]  Y. Maehara,et al.  Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. , 2007, Journal of the American College of Surgeons.

[21]  N. Ohkohchi,et al.  Platelets Promote Liver Regeneration in Early Period after Hepatectomy in Mice , 2007, World Journal of Surgery.

[22]  W. Jochum,et al.  Platelets and platelet‐derived serotonin promote tissue repair after normothermic hepatic ischemia in mice , 2007, Hepatology.

[23]  W. Jochum,et al.  Platelet-Derived Serotonin Mediates Liver Regeneration , 2006, Science.

[24]  J. Bragg-Gresham,et al.  Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  David Mayer,et al.  Hepatic artery thrombosis following orthotopic liver transplantation: A 10‐year experience from a single centre in the United Kingdom , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  P. Clavien,et al.  Small‐for‐Size Syndrome After Partial Liver Transplantation: Definition, Mechanisms of Disease and Clinical Implications , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  K. Kaneko,et al.  Low preoperative platelet counts predict a high mortality after partial hepatectomy in patients with hepatocellular carcinoma. , 2005, World journal of gastroenterology.

[28]  B. Reiser,et al.  Estimation of the Youden Index and its Associated Cutoff Point , 2005, Biometrical journal. Biometrische Zeitschrift.

[29]  E. Vamvakas.  Platelet transfusion and adverse outcomes , 2004, The Lancet.

[30]  S. Fan,et al.  Improving Perioperative Outcome Expands the Role of Hepatectomy in Management of Benign and Malignant Hepatobiliary Diseases: Analysis of 1222 Consecutive Patients From a Prospective Database , 2004, Annals of surgery.

[31]  M. Wojtukiewicz,et al.  Platelets and angiogenesis in malignancy. , 2004, Seminars in thrombosis and hemostasis.

[32]  S. Fan,et al.  Portal hyperperfusion injury as the cause of primary nonfunction in a small‐for‐size liver graft‐successful treatment with splenic artery ligation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[33]  M. Selsted,et al.  Antimicrobial Peptides from Human Platelets , 2002, Infection and Immunity.

[34]  Yuman Fong,et al.  Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade , 2002, Annals of surgery.

[35]  P. Clavien,et al.  Medical Care of the Liver Transplant Patient , 2001 .

[36]  M. Nijsten,et al.  Blunted rise in platelet count in critically ill patients is associated with worse outcome , 2000, Critical care medicine.

[37]  Nina Singh,et al.  Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. , 2000, Transplantation.

[38]  C. Sprung,et al.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. , 1998, Critical care medicine.

[39]  M. V. Boland,et al.  Multivariate Analysis , 1998, Current protocols in cytometry.

[40]  G. Alexander,et al.  Thrombocytopenia following liver transplantation is associated with platelet consumption and thrombin generation , 1997, British journal of haematology.

[41]  M. Klinger.  Platelets and inflammation , 1997, Anatomy and Embryology.

[42]  K K Wu,et al.  Platelet activation mechanisms and markers in arterial thrombosis , 1996, Journal of internal medicine.

[43]  C. Sprung,et al.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.

[44]  J. Sanabria,et al.  Role of platelets in hepatic allograft preservation injury in the rat , 1993, Hepatology.

[45]  M. Stegall,et al.  Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. , 1993, Transplantation.

[46]  M. O’Connor,et al.  Thrombocytopenia after liver transplantation. , 1988, Transplantation proceedings.

[47]  R. Bentley,et al.  Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. , 2000, Gastroenterology.

[48]  G. Escolar,et al.  Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation. , 1999, Haematologica.

[49]  J. Thompson,et al.  Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. , 1992, Journal of hepatology.

[50]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.

[51]  M. Makuuchi,et al.  The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.